Assembly Biosciences earnings missed by $0.03, revenue was in line with estimates

  • Investing.com
Assembly Biosciences earnings missed by $0.03, revenue was in line with estimates

Investing.com - Assembly Biosciences (NASDAQ: ASMB ) reported third quarter EPS of $-0.270, $0.03 worse than the analyst estimate of $-0.240. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.

Assembly Biosciences's stock price closed at $0.850. It is down -19.050% in the last 3 months and down -36.890% in the last 12 months.

Assembly Biosciences saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Assembly Biosciences's stock price’s past reactions to earnings here.

According to InvestingPro, Assembly Biosciences's Financial Health score is "fair performance".

Check out Assembly Biosciences's recent earnings performance , and Assembly Biosciences's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100